摘要:
Ethylenically unsaturated glycosides of formula (I) wherein n, A, X, R 3 and R 4 have the meanings given in the description are produced by reacting an ethylenically unsaturated alcohol of formula (II) with a saccharide of formula (III) in the presence of a glycosidase, such as an amylase, cellulase, glucosidase or galactosidase, (i) at a molar ratio of ethylenically unsaturated alcohol of formula II to saccharide of formula (III) of from 2:1 to 30:1; (ii) in the presence of a solvent mixture of water and a water miscible organic solvent that is no primary or secondary alcohol, such as acetone, acetonitrile, t-pentanol, t-butanol, 1,4-dioxane and tetrahydrofuran, at a weight ratio of water to organic solvent of from 0.1 :1 to 9:1; and (iii) at a weight ratio of solvent mixture to saccharide of from 3:1 to 30:1.
摘要:
Ethylenically unsaturated glycosides of formula (I) wherein n, A, X, R3 and R4 have the meanings given in the description are produced by reacting an ethylenically unsaturated alcohol of formula (II) with a saccharide of formula (III) in the presence of a glycosidase, such as an amylase, cellulase, glucosidase or galactosidase, (i) at a molar ratio of ethylenically unsaturated alcohol of formula II to saccharide of formula (III) of from 2:1 to 30:1; (ii) in the presence of a solvent mixture of water and a water miscible organic solvent that is no primary or secondary alcohol, such as acetone, acetonitrile, t-pentanol, t-butanol, 1,4-dioxane and tetrahydrofuran, at a weight ratio of water to organic solvent of from 0.1 :1 to 9:1; and (iii) at a weight ratio of solvent mixture to saccharide of from 3:1 to 30:1.
摘要:
Provided herein are branched oligonucleotides exhibiting efficient and specific tissue distribution, cellular uptake, minimum immune response and off-target effects, without formulation.
摘要:
The present application relates to the compounds of formula I (I) as well as their use for inhibiting at least one of AKT-1, FAK and PKCα and in the treatment and/or prevention of metastatic diseases.
摘要:
The invention provides for double stranded nucleic acid molecules comprising a 5 'extension of the sense or antisense strand and further comprising a plurality of nucleotides that are conjugated to a ligand and methods of using the double-stranded nucleic acid molecules. Ligand-modified oligomers where the sense stands form a tetraloop provide new potent and stable RNA interference agents. These dsNA molecules are synthesized using a plurality of nucleotides that include ligand-modified monomers, nucleotide analog monomers, modified nucleotide monomers and the like, using standard nucleotide synthetic methods and systems.